Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized remimazolam dosing under total intravenous anesthesia
ChiCTR2300074375Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Onset time of anesthesia and Duration of anesthesia. Started Aug 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300074375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074375.